DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
de Lédinghen V, Laforest C, Hézode C. , et al.
Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed an NS5A- or NS3-containing regimen: the ANRS HC34 REVENGE Study.
Clin Infect Dis 2018;
66 (07) 1013-1018
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.